GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Dividend Yield %

Longevity Biomedical (Longevity Biomedical) Dividend Yield % : 0.00% (As of May. 20, 2024)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Dividend Yield %?

As of today (2024-05-20), the Trailing Annual Dividend Yield of Longevity Biomedical is 0.00%.

The historical rank and industry rank for Longevity Biomedical's Dividend Yield % or its related term are showing as below:

LBIO's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.365
* Ranked among companies with meaningful Dividend Yield % only.

Longevity Biomedical's Dividend Payout Ratio for the six months ended in . 20 was 0.00.

As of today (2024-05-20), the Forward Dividend Yield % of Longevity Biomedical is 0.00%.

Longevity Biomedical's Dividends per Share for the six months ended in . 20 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Longevity Biomedical Dividend Yield % Historical Data

The historical data trend for Longevity Biomedical's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Dividend Yield % Chart

Longevity Biomedical Annual Data
Trend
Dividend Yield %

Longevity Biomedical Semi-Annual Data
Dividend Yield %

Competitive Comparison of Longevity Biomedical's Dividend Yield %

For the Biotechnology subindustry, Longevity Biomedical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Dividend Yield % falls into.



Longevity Biomedical Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Longevity Biomedical  (NAS:LBIO) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Longevity Biomedical Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines